October 22, 2026 Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)
The book achieved top seller status as a New Release in Vermont Travel Guides category
The book achieved top seller status as a New Release in Vermont Travel Guides category 
